These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9821715)

  • 1. Type III D mucopolysaccharidosis (Sanfilippo D): clinical course and symptoms.
    Tylki-Szymańska A; Czartoryska B; Górska D; Piesiewicz-Grzonkowska E
    Acta Paediatr Jpn; 1998 Oct; 40(5):492-4. PubMed ID: 9821715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sanfilippo type D presenting with acquired language disorder but without features of mucopolysaccharidosis.
    Ozand PT; Thompson JN; Gascon GG; Sarvepalli SB; Rahbeeni Z; Nester MJ; Brismar J
    J Child Neurol; 1994 Oct; 9(4):408-11. PubMed ID: 7822734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical heterogeneity in Sanfilippo disease (mucopolysaccharidosis III) type D: presentation of two new cases.
    Coppa GV; Giorgi PL; Felici L; Gabrielli O; Donti E; Bernasconi S; Kresse H; Paschke E; Mastropaolo C
    Eur J Pediatr; 1983 Apr; 140(2):130-3. PubMed ID: 6411475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperactivity and behavioral disorders in Sanfilippo A (mucopolysaccharidosis type IIIA)--case report and review of the literature].
    Wolańczyk T; Banaszkiewicz A; Mierzewska H; Czartoryska B; Zdziennicka E
    Psychiatr Pol; 2000; 34(5):831-7. PubMed ID: 11202024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sanfilippo type D disease: clinical findings in two patients with a new variant of mucopolysaccharidosis III.
    Gatti R; Borrone C; Durand P; De Virgilis S; Sanna G; Cao A; von Figura K; Kresse H; Paschke E
    Eur J Pediatr; 1982 Mar; 138(2):168-71. PubMed ID: 6807676
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperactivity, unexplained speech delay, and coarse facies--is it Sanfilippo syndrome?
    Saini AG; Singhi P; Sahu JK; Ganesan SL; Vyas S; Rao S; Sachdeva MU
    J Child Neurol; 2014 Aug; 29(8):NP9-12. PubMed ID: 23761035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sanfilippo disease type D: deficiency of N-acetylglucosamine-6-sulfate sulfatase required for heparan sulfate degradation.
    Kresse H; Paschke E; von Figura K; Gilberg W; Fuchs W
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6822-6. PubMed ID: 6450420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of the Sanfilippo D syndrome by the use of a radiolabeled monosaccharide sulfate as the substrate for the estimation of N-acetylglucosamine-6-sulfate sulfatase.
    Elliott H; Hopwood JJ
    Anal Biochem; 1984 Apr; 138(1):205-9. PubMed ID: 6428270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild Sanfilippo syndrome: a further cause of hyperactivity and behavioural disturbance.
    Wraith JE; Danks DM; Rogers JG
    Med J Aust; 1987 Nov; 147(9):450-1. PubMed ID: 3118155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From hypertransaminasemia to mucopolysaccharidosis IIIA.
    Krawiec P; Pac-Kożuchowska E; Mełges B; Mroczkowska-Juchkiewicz A; Skomra S; Pawłowska-Kamieniak A; Kominek K
    Ital J Pediatr; 2014 Dec; 40():97. PubMed ID: 25439061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sanfilippo D syndrome: estimation of N-acetylglucosamine-6-sulfatase activity with a radiolabeled monosulfated disaccharide substrate.
    Freeman C; Hopwood JJ
    Anal Biochem; 1989 Feb; 176(2):244-8. PubMed ID: 2500866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mucopolysaccharidosis type III (Sanfilippo syndrome)].
    Sukegawa K; Tomatsu S; Kondo N; Orii T
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):439-41. PubMed ID: 9645103
    [No Abstract]   [Full Text] [Related]  

  • 13. Genomic basis of mucopolysaccharidosis type IIID (MIM 252940) revealed by sequencing of GNS encoding N-acetylglucosamine-6-sulfatase.
    Mok A; Cao H; Hegele RA
    Genomics; 2003 Jan; 81(1):1-5. PubMed ID: 12573255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sanfilippo Syndrome].
    Osipova LA; Kuzenkova LM; Namazova-Baranova LS; Gevorkyan AK; Podkletnova TV; Vashakmadze ND
    Vestn Ross Akad Med Nauk; 2015; (4):419-27. PubMed ID: 26710524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome).
    Barone R; Nigro F; Triulzi F; Musumeci S; Fiumara A; Pavone L
    Neuropediatrics; 1999 Oct; 30(5):270-4. PubMed ID: 10598840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sanfilippo type C syndrome in two sisters.
    Uvebrant P
    Acta Paediatr Scand; 1985 Jan; 74(1):137-9. PubMed ID: 3920864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth charts for patients with Sanfilippo syndrome (Mucopolysaccharidosis type III).
    Muschol NM; Pape D; Kossow K; Ullrich K; Arash-Kaps L; Hennermann JB; Stücker R; Breyer SR
    Orphanet J Rare Dis; 2019 May; 14(1):93. PubMed ID: 31046785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The laboratory diagnosis of Sanfilippo disease.
    Whiteman P; Young E
    Clin Chim Acta; 1977 Apr; 76(1):139-47. PubMed ID: 404099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic complementation studies of multiple sulfatase deficiency.
    Horwitz AL
    Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6496-9. PubMed ID: 118467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylglucosamine 6-sulphatase deficiency in a Nubian goat: a model of Sanfilippo syndrome type D (mucopolysaccharidosis IIID).
    Thompson JN; Jones MZ; Dawson G; Huffman PS
    J Inherit Metab Dis; 1992; 15(5):760-8. PubMed ID: 1434515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.